Chandraiah Lagisetti

age ~49

from San Diego, CA

Also known as:
  • Lagisetti Chandraiah

Chandraiah Lagisetti Phones & Addresses

  • San Diego, CA
  • Monroe, NC
  • Cupertino, CA
  • Collierville, TN
  • Urbana, IL
  • Memphis, TN
  • Champaign, IL

Us Patents

  • Anticancer Compounds And Methods Of Making And Using Same

    view source
  • US Patent:
    20110178098, Jul 21, 2011
  • Filed:
    Jun 22, 2009
  • Appl. No.:
    12/999218
  • Inventors:
    Thomas R. Webb - Millington TN, US
    Chandraiah Lagisetti - Memphis TN, US
  • International Classification:
    A61K 31/496
    C07D 493/10
    C12N 5/00
    A61K 31/4025
    A61P 35/00
    A61P 35/02
    A61K 31/4433
    A61K 31/506
    A61K 31/357
  • US Classification:
    5142541, 548407, 435375, 514409, 549 28, 546 15, 514278, 544230, 514256, 549370, 514452
  • Abstract:
    In one aspect, the invention relates to compounds having anticancer activity; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with uncontrolled cellular proliferation using the compounds and compositions. This abstract is intended to be used as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • Dual Clk/Cdk1 Inhibitors For Cancer Treatment

    view source
  • US Patent:
    20200390772, Dec 17, 2020
  • Filed:
    May 28, 2020
  • Appl. No.:
    16/886290
  • Inventors:
    - Menlo Park CA, US
    Jaehyeon Park - Sunnyvale CA, US
    Chandraiah Lagisetti - Cupertino CA, US
  • International Classification:
    A61K 31/52
    A61P 35/00
    C07D 473/32
    C07D 473/16
    A61K 31/437
  • Abstract:
    The disclosure generally relates to substituted purine analogs that are dual CLK2/CDK1 inhibitors or more potent and specific CLK inhibitors to target CLK2 and CDK1 kinases. These compounds may be useful in the treatment of germ-line mutations of the spliceosome leading to the development of cancers and other human disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • Dual Clk/Cdk1 Inhibitors For Cancer Treatment

    view source
  • US Patent:
    20190255059, Aug 22, 2019
  • Filed:
    Sep 29, 2017
  • Appl. No.:
    16/334229
  • Inventors:
    - Mento Park CA, US
    Jaehyeon Park - Sunnyvale CA, US
    Chandraiah Lagisetti - Cupertino CA, US
  • International Classification:
    A61K 31/52
    A61P 35/00
    C07D 473/32
  • Abstract:
    This disclosure generally relates to dual CLK2/CDK1 inhibitors or more potent and specific CLK inhibitors to target CLK2 and CDK1 kinases in the treatment of germ-line mutations of the spliceosome leading to the development of cancers and other human disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • Anticancer Compounds

    view source
  • US Patent:
    20160009728, Jan 14, 2016
  • Filed:
    Dec 9, 2013
  • Appl. No.:
    14/650826
  • Inventors:
    - Memphis TN, US
    Chandraiah Lagisetti - Collierville TN, US
  • International Classification:
    C07D 493/10
  • Abstract:
    In one aspect, the invention relates to compounds having anticancer activity; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with uncontrolled cellular proliferation using the compounds and compositions. This abstract is intended to be used as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Get Report for Chandraiah Lagisetti from San Diego, CA, age ~49
Control profile